Page last updated: 2024-11-05

triazolam and Rhabdomyolysis

triazolam has been researched along with Rhabdomyolysis in 1 studies

Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.

Rhabdomyolysis: Necrosis or disintegration of skeletal muscle often followed by myoglobinuria.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Strohmaier, A1
Friedrich, M1

Other Studies

1 other study available for triazolam and Rhabdomyolysis

ArticleYear
[A nontraumatic compartment syndrome of both lower legs resulting from acute rhabdomyolysis].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1991, Volume: 155, Issue:3

    Topics: Acute Disease; Adolescent; Alcoholic Intoxication; Compartment Syndromes; Drug Overdose; Fasciotomy;

1991